{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:43:41Z","timestamp":1793245421360,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endodontics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.don.0000186481.96169.cd","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T08:01:32Z","timestamp":1129622492000},"page":"831-834","source":"Crossref","is-referenced-by-count":48,"title":["Endodontic Implications of Bisphosphonate-Associated Osteonecrosis of the Jaws: A Report of Three Cases"],"prefix":"10.1016","volume":"31","author":[{"given":"Harmon","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.don.0000186481.96169.cd_bib1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib2","unstructured":"Bisphosphonates. http:\/\/courses.washington.edu\/bonephys\/opbis.html (accessed August 1, 2005)."},{"key":"10.1097\/01.don.0000186481.96169.cd_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00063030-200418040-00004","article-title":"Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities","volume":"18","author":"Santini","year":"2004","journal-title":"BioDrugs"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0889-857X(03)00028-0","article-title":"New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate","volume":"29","author":"Davis","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib5","first-page":"CD003474","article-title":"Bisphosphonates for breast cancer","author":"Pavlakis","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0305-7372(03)00071-9","article-title":"Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment","volume":"29","author":"Eaton","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2004.11.075","article-title":"Alternative bisphosphonate targets and mechanisms of action","volume":"328","author":"Bukowski","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP61063","article-title":"Pamidronate-induced nephrotoxic tubular necrosis: a case report","volume":"61","author":"Smetana","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(05)76114-6","article-title":"Increased cytokines and pamidronate-induced bone pain in adults with cystic fibrosis","volume":"353","author":"Teramoto","year":"1999","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1097\/01.don.0000186481.96169.cd_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.47102\/annals-acadmedsg.V33N4p48S","article-title":"Bisphosphonates: a word of caution","volume":"33","author":"Robinson","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Maerevoet","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Woo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1188\/05.CJON.355-357","article-title":"Exposed bone in oral cavities","volume":"9","author":"Viale","year":"2005","journal-title":"Clin J Oncol Nurs"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.2005.tb06761.x","article-title":"Bisphosphonates and avascular necrosis of the jaw: a possible association","volume":"182","author":"Carter","year":"2005","journal-title":"Med J Aust"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib19","first-page":"161, 163","article-title":"Nonhealing extraction site","volume":"53","author":"Philipone","year":"2005","journal-title":"Gen Dent"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","article-title":"Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma","volume":"128","author":"Vannucchi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tripleo.2004.10.001","article-title":"Bisphosphonate-associated oral osteonecrosis","volume":"99","author":"Migliorati","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","article-title":"Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity","volume":"117","author":"Lugassy","year":"2004","journal-title":"Am J Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and osteonecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.joms.2003.11.003","article-title":"Bisphosphonates and bone necrosis","volume":"62","author":"Pogrel","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib27","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter","year":"2003","journal-title":"Aust Dent J"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib28","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","article-title":"Avascular necrosis of the jaws: risk factors in metastatic cancer patients","volume":"61","author":"Tarassoff","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib31","first-page":"99","article-title":"Letter to the Editor","volume":"353","author":"Tarassoff","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.joms.2004.03.005","article-title":"Osteonecrosis and bisphosphonates: correlation versus causation","volume":"62","author":"Schwartz","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib33","unstructured":"News FPS. Show #34, December 2004. Available for viewing at http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/psn\/printer.cfm?id=276."},{"key":"10.1097\/01.don.0000186481.96169.cd_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1902\/annals.2003.8.1.12","article-title":"Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review","volume":"8","author":"Reddy","year":"2003","journal-title":"Ann Periodontol"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib35","first-page":"331","article-title":"[Influence of biphosphonates on the integration process of endosseous implants evaluated using single photon emission computerized tomography (SPECT)]","volume":"52","author":"Bambini","year":"2003","journal-title":"Minerva Stomatol"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib36","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/S0142-9612(01)00415-X","article-title":"Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants","volume":"23","author":"Yoshinari","year":"2002","journal-title":"Biomaterials"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1902\/jop.2003.74.1.44","article-title":"The influence of alendronate on bone formation and resorption in a rat ectopic bone development model","volume":"74","author":"Yaffe","year":"2003","journal-title":"J Periodontol"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJM200407083510218","article-title":"Ten years of alendronate treatment for osteoporosis in postmenopausal women","volume":"351","author":"Ruggiero","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.don.0000182737.09980.2c","article-title":"Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports","volume":"31","author":"Sarathy","year":"2005","journal-title":"J Endod"},{"key":"10.1097\/01.don.0000186481.96169.cd_bib41","unstructured":"Novartis PC. Important drug precaution for dental health professionals with patients being treated for cancer [letter to dentists]. Rockville, MD: US Food and Drug Administration; 2005 May 5. Available: http:\/\/www.fda.gov\/medwatch\/safety\/2005\/safety05.htm-zometa2 (accessed: August 1, 2005)."}],"container-title":["Journal of Endodontics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099239906610881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0099239906610881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T02:17:47Z","timestamp":1706667467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0099239906610881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0099239906610881"],"URL":"https:\/\/doi.org\/10.1097\/01.don.0000186481.96169.cd","relation":{},"ISSN":["0099-2399"],"issn-type":[{"value":"0099-2399","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}